5 results
• To assess contraceptive efficacy, vaginal bleeding patterns (cycle control),general safety and acceptability of the NOMAC-E2 COC in a large group ofwomen aged 18-50 years.
To evaluate the effects on ovarian function with the NOMAC/E2 COC in a group of women aged 18-35 years.
To determine the maximum tolerated doses (MTDs) and dose-limiting toxicities (DLTs) of nelarabine, etoposide and cyclophosphamide when given in combination to children with T-ALL and bone marrow relapse or T-LL.
The primary objective of this study is to demonstrate efficacy of BIIB059compared with placebo in participants with active systemic lupuserythematosus (SLE), who are receiving background lupus standard ofcare (SOC) therapy in reducing disease…
The Primary Objective of this Clinical Trial is to evaluate the long-term safety and tolerability of litifilimab in participants with active SLE.The Secondary Objectives of this Clinical Trial are:- to evaluate the long-term effect of litifilimab on…